In conclusion, CIHH decreased high blood pressure in SHRs, which may have occurred by inhibiting RAS activity, downregulating the ACE-Ang II-AT1 receptor axis, and upregulating the ACE2-(Ang1–7)-Mas receptor axis. This evidence concerns the gene ACE and hypertensive disorder.